21 results on '"Vanoli, J"'
Search Results
2. Coffee consumption, clinic, 24-hour and home blood pressure. Findings from the pamela study
- Author
-
Fosca Quarti-Trevano, Raffaella Dell’Oro, Jennifer Vanoli, Michele Bombelli, Rita Facchetti, Giuseppe Mancia, Guido Grassi, Quarti-Trevano, F, Dell'Oro, R, Vanoli, J, Bombelli, M, Facchetti, R, Mancia, G, and Grassi, G
- Subjects
Blood pressure variability ,Nutrition and Dietetics ,Endocrinology, Diabetes and Metabolism ,Heart rate ,Home blood pressure ,Clinic blood pressure ,Medicine (miscellaneous) ,Ambulatory blood pressure ,Cardiology and Cardiovascular Medicine ,Coffee - Abstract
Background and aims: Chronic coffee consuption has been reported to be associated with a modest but significant increase in blood pressure (BP), although some recent studies have shown the opposite. These data, however, largely refer to clinic BP and virtually no study evaluated cross-sectionally the association between chronic coffee consuption, out-of-office BP and BP variability. Methods and results: In 2045 subjects belonging to the population of the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study, we analyzed cross-sectionally the association between clinic, 24-hour, home BP and BP variability and level of chronic coffee consumption. Results show that when adjusted for confounders (age, gender, body mass index, cigarette smoking, physical activity and alcohol drinking) chronic coffee consumption does not appear to have any major lowering effect on BP values, particulary when they are assessed via 24-hour ambulatory (0 Cup/day: 118.5±0.7/72.8±0.4mmHg vs 3 cups/day: 120.2±0.4/74.8±0.3mmHg, PNS) or home BP monitoring (0 cup/day: 124.1±1.2/75.4±0.7mmHg vs 3 cups/day: 123.3±0.6/76.4±0.36mmHg, PNS). However, daytime BP was significantly higher in coffee consumers (about 2mmHg), suggesting some pressor effects of coffee which vanish during nighttime. Both BP and HR 24-hour HR variability were unaffected. Conclusion: Thus chronic coffee consumption does not appear to have any major lowering effect either on absolute BP values, particulary when they are assessed via 24-hour ambulatory or home BP monitoring, or on 24-hour BP variability.
- Published
- 2023
3. Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
- Author
-
Guido Grassi, Gino Seravalle, Jennifer Vanoli, Rita Facchetti, Domenico Spaziani, Giuseppe Mancia, Grassi, G, Seravalle, G, Vanoli, J, Facchetti, R, Spaziani, D, and Mancia, G
- Subjects
Sympathetic nerve traffic ,Cardiovascular mortality ,Heart rate ,Sympathetic activity ,Heart failure ,Cardiovascular morbidity ,General Medicine ,Cardiology and Cardiovascular Medicine ,Plasma norepinephrine - Abstract
Background Results of recent clinical trials have shown that in heart failure (HF) heart rate (HR) values > 70 beats/minute are associated with an increased cardiovascular risk. No information is available on whether the sympathetic nervous system is differently activated in HF patients displaying resting HR values above or below this cutoff. Methods In 103 HF patients aged 62.7 ± 0.9 (mean ± SEM) years and in 62 heathy controls of similar age we evaluated muscle sympathetic nerve traffic (MSNA, microneurography) and venous plasma norepinephrine (NE, HPLC assay), subdividing the subjects in different groups according to their resting clinic and 24-h HR values. Results In HF progressively greater values of clinic or 24-h HR were associated with a progressive increase in both MSNA and NE. HR cutoff values adopted in large scale clinical trials for determining cardiovascular risk, i.e., 70 beats/minute, were associated with MSNA values significantly greater than the ones detected in patients with lower HR, this being the case also for NE. In HF both MSNA and NE were significantly related to clinic (r = 0.92, P r = 0.81, P r = 0.91, P r = 0.79, P Conclusions Both clinic and 24-h HR values greater than 70 beats/minute are associated with an increased sympathetic activation, which parallels for magnitude the HR elevations. These findings support the relevance of using in the therapeutic approach to HF drugs exerting sympathomoderating properties. Graphical abstract
- Published
- 2022
4. Impact of the Increase in Left Ventricular Mass on the Risk of Long-Term Cardiovascular Mortality: A Prospective Cohort Study
- Author
-
Michele Bombelli, Jennifer Vanoli, Rita Facchetti, Alessandro Maloberti, Cesare Cuspidi, Guido Grassi, Giuseppe Mancia, Bombelli, M, Vanoli, J, Facchetti, R, Maloberti, A, Cuspidi, C, Grassi, G, and Mancia, G
- Subjects
cardiovascular risk ,left ventricular ma ,Internal Medicine ,glucose ,cardiovascular event ,participant - Abstract
Background: Left ventricular hypertrophy (LVH) is an independent predictor of cardiovascular events, and evidence has been obtained that an increase of a normal left ventricular mass (LVM) or new-onset LVH over time augments cardiovascular outcomes. Methods: We addressed this issue in a sample of a general population at relatively low cardiovascular risk. We analyzed subjects with normal echocardiographic LVM enrolled in the PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study to follow the increase of LVM over time and assess the prognostic impact of this change on the incidence of cardiovascular events (mean follow-up 18.5 years). Results: In 990 subjects with no LVH at baseline, there was a significant average increase of LVM (21.2%), LVMI BSA (18.9%), and LVMI HT (22.3%) more than 10 years later. About a quarter developed LVH. The LVMI BSA change exhibited an association with the cardiovascular risk mortality during the following 18.5 years, and the association remained significant after adjustment for confounders (hazard ratio, 1.2 [1.0–1.5]). Similar findings were obtained for LVM in absolute values or indexed for height. The association was seen in both genders, but the link with the cardiovascular risk was statistically significant in males only. Conclusions: Thus, although over 10 years, the LVM increase does not reach a LVH status, it is associated with an augmented cardiovascular mortality risk. This suggests that it might be important to consider periodical LVM assessment, even when LVM is within the normal range, to timely detect its increase and cope with the need of cardiovascular risk restratification.
- Published
- 2023
5. Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy
- Author
-
Michele Bombelli, Jennifer Vanoli, Cesare Cuspidi, Raffaella Dell'Oro, Rita Facchetti, Giuseppe Mancia, Guido Grassi, Bombelli, M, Vanoli, J, Cuspidi, C, Dell'Oro, R, Facchetti, R, Mancia, G, and Grassi, G
- Subjects
Endocrinology, Diabetes and Metabolism ,electrocardiography ,left ventricular ma ,Internal Medicine ,echocardiography ,Cardiology and Cardiovascular Medicine ,left ventricular hypertrophy - Abstract
We assessed the value of 3 electrocardiographic (EKG) voltage criteria in detecting variations of left ventricular mass (LVM) over time, taking echocardiographic (ECHO) LVM as reference, in the Pressioni Arteriose Monitorate E Loro Associazioni study. In 927 subjects (age 47 +/- 13 years on entry, 49.9% men) an ECHO evaluation of LVM and EKG suitable for measurement of EKG-LVH criteria (Sokolow-Lyon voltage, Cornell voltage and R-wave voltage in aVL) were available at baseline and at a 2(nd) evaluation performed 10 years later. Delta (delta) LVM, Delta LVMI, and Delta EKG parameters values were calculated from 2(nd) evaluation to baseline. The sensitivity of the EKG criteria in the diagnosis of LVH, poor at baseline, becomes even worse after 10 years, reaching very low values. Only the sensitivity of R-wave amplitude exhibited slight increase over time but with unsatisfactory absolute values. Despite the prevalence of ECHO-LVH at the 2(nd) evaluation was threefold increased compared to baseline (29.3% and 33.7% for LVM indexed to BSA and height(2.7), respectively), the prevalence of EKG-LVH was unchanged when evaluated by Sokolow-Lyon criteria, significantly reduced when assessed by Cornell voltage index, while significantly increased using R-wave voltage in aVL criteria. Despite an ECHO-LVM increase over the time, mean EKG changes were of opposite sign, except for R-wave amplitude in aVL. Our study highlights the discrepancy between ECHO and EKG in monitoring LVM changes over the time, especially for Sokolow-Lyon and Cornell voltage. Thus, EKG is an unsuitable method for the longitudinal evaluation of LVM variations.
- Published
- 2023
6. Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study
- Author
-
Guido Grassi, Jennifer Vanoli, Rita Facchetti, Giuseppe Mancia, Grassi, G, Vanoli, J, Facchetti, R, and Mancia, G
- Subjects
Blood pressure variability ,Phenotype ,Office blood pressure ,Hypertension ,Home blood pressure ,Internal Medicine ,Humans ,Blood Pressure ,Organ damage ,Ambulatory blood pressure ,Blood Pressure Monitoring, Ambulatory ,Cardiovascular risk ,Uric Acid - Abstract
Purpose of Review To examine published and unpublished data collected in the context of the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study on the relationships between serum uric acid (SUA), office and out-of-office blood pressure (BP), and organ damage. Recent Findings SUA values were directly and significantly related to a large number of covariates that participate at cardiovascular risk determination, such as blood glucose, total serum cholesterol, serum triglycerides, body mass index, and serum creatinine. Additional variables included echocardiographically-determined left ventricular mass index and BP values, the latter not just when measured in the office but also when evaluated at home or over the 24-h period. White-coat hypertension and masked hypertension were characterized, as sustained hypertension, by a significant increase in SUA levels, which were also directly related to different indices of 24-h BP variability. No substantial difference in SUA levels was found when data were analyzed according to the dipping or non-dipping nocturnal BP profile. Summary Data collected in the frame of the PAMELA study document the presence of a close relationship between SUA levels and BP values independently on the hypertensive phenotype patterns of BP increase (office, 24 h, or both) and nighttime BP profile. They also document the increase in SUA as a potential factor favoring the occurrence of new hypertension and new left ventricular hypertrophy.
- Published
- 2022
7. Association between Berlin questionnaire index and blood pressure, organ damage and metabolic profilein a general population
- Author
-
Jennifer Vanoli, Raffaella Dell'Oro, Rita Facchetti, Michele Bombelli, Giuseppe Mancia, Guido Grassi, Vanoli, J, Dell'Oro, R, Facchetti, R, Bombelli, M, Mancia, G, and Grassi, G
- Subjects
Male ,Endocrinology, Diabetes and Metabolism ,risk assessment ,ambulatory blood pressure/home blood pressure monitor ,Blood Pressure ,Middle Aged ,Blood Pressure Monitoring, Ambulatory ,sleep problems and hypertension ,Surveys and Questionnaires ,Hypertension ,Internal Medicine ,Humans ,Hypertrophy, Left Ventricular ,Cardiology and Cardiovascular Medicine ,Antihypertensive Agents ,Aged - Abstract
We evaluated the relationships between Berlin questionnaire (BQ) scores, hypertension and other metabolic variables in 598 subjects (age: 65.8 ± 10 years, mean ± SD) enrolled in the PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study representative of the general population, treated or untreated with antihypertensive drugs. Two hundred and eleven subjects (35%) had a positive BQ with two or more positive categories of the inquiry. Compared to those without sleep disorders these subjects showed a greater male prevalence (55.9%), worse serum cholesterol, triglycerides and glucose profile, greater body mass index (BMI) (28.9 ± 4.9 vs. 24.9 ± 3.4 kg/m2), higher office (and to a lesser extent 24-h) BP and HR values, higher serum creatinine values and greater rate of echocardiographic left ventricular (LV) hypertrophy (25% vs. 13%). These differences were not detected when the data analysis was restricted to treated hypertensive patients. Thus, BQ scores allow to identify among subjects belonging to a general population those with elevated BP, organ damage and altered metabolic. When antihypertensive drug treatment is present, however, the approach fails to detect differences between groups with low or high BQ index.
- Published
- 2022
8. Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome
- Author
-
Gino Seravalle, Jennifer Vanoli, Concetta Molisano, Valeria Merati, Guido Grassi, Seravalle, G, Vanoli, J, Molisano, C, Merati, V, and Grassi, G
- Subjects
Sympathetic nerve traffic ,Metabolic Syndrome ,Sympathetic Nervous System ,Endocrinology, Diabetes and Metabolism ,Blood Pressure ,General Medicine ,Cardiovascular risk ,Norepinephrine ,Endocrinology ,Cardiovascular Diseases ,Heart Disease Risk Factors ,Heart Rate ,Risk Factors ,Internal Medicine ,Humans ,Muscle, Skeletal - Abstract
Aims We examined whether to what extent resting heart rate (HR) values are capable to reflect in the metabolic syndrome (MS) a different degree of sympathetic activation. We also thought to determine at which HR cutoff values the sympathetic nervous system becomes more activated in the MS. Methods In 70 MS patients aged 55.5 ± 1.8 (mean ± SEM) years we evaluated muscle sympathetic nerve traffic (MSNA, microneurography) and venous plasma norepinephrine (NE, HPLC assay), subdividing the study population in three different subgroups according to resting clinic and 24-h HR values ( Results MS patients with clinic HR values ≥ 80 beats/min displayed MSNA and NE values significantly increased when compared to those found in MS with HR between 70 and 79 beats/min or below 70 beats/min (MSNA: 55.2 ± 0.9 vs 44.6 ± 0.6 and 39.2 ± 0.6 bursts/min, P P r = 0.89 and r = 0.91, P Conclusions In the MS HR values ≥ 80 beats/min are associated with an increased sympathetic activation, both when assessed by direct recording of MSNA and when evaluated as plasma NE. The sympathetic overdrive parallels for magnitude the HR elevations, this being the case for both clinic and 24-h HR.
- Published
- 2022
9. Metronidazole-induced hepatotoxicity in a patient with xeroderma pigmentosum: A case report
- Author
-
Vanoli, Jennifer, Nava, Miriam, Invernizzi, Chiara, Panizzuti, Fabio, Grassi, Guido, Vanoli, J, Nava, M, Invernizzi, C, Panizzuti, F, and Grassi, G
- Subjects
Adult ,Male ,Xeroderma Pigmentosum ,DNA Repair ,acute hepatiti ,liver failure ,General Medicine ,Anti-Bacterial Agents ,antibiotic ,Metronidazole ,case report ,Humans ,Chemical and Drug Induced Liver Injury ,drug-induced liver injury - Abstract
Rationale:Whereas metronidazole-induced hepatotoxicity is quite rare in the general population, in individuals carrying a nucleotide excision repair disorder, namely Cockayne syndrome, there is a high risk of developing this complication.Patient concerns:We report the case of a 44-year-old man, affected by xeroderma pigmentosum, who was admitted to the hospital presenting aspiration pneumoniae caused by worsening dysphagia and with severe hepatotoxicity during the hospitalization.Diagnoses:Acute hepatitis, which was leading to acute liver failure, occurred during antibiotic treatment with metronidazole and ceftazidime with an elevation of liver enzymes consistent with hepatocellular damage pattern.Interventions:Hydration with glucose 5% solution, pantoprazole and vitamin K were administered, meanwhile other causes of hepatitis were ruled out and the ongoing antibiotic treatment was stopped suspecting a drug-induced liver injury.Outcomes:Liver function nearly completely recovered 1 month later with a first rapid improvement, within few days, of aminotransferases and coagulation studies, and slower of cholestatic enzymes.Lessons:We describe the first case available in the literature of hepatotoxicity associated with metronidazole treatment in a xeroderma pigmentosum patient. Clinicians therefore, based on this report and according to the possible underlying mechanism shared by other genetic diseases characterized by alterations in the pathway of DNA-repair, should consider such adverse event also in patients affected by this rare disease.
- Published
- 2022
10. Postnatal exposure to PM2.5 and weight trajectories in early childhood
- Author
-
Jacopo Vanoli, Brent A. Coull, Stephanie Ettinger de Cuba, Patricia M. Fabian, Fei Carnes, Marisa A. Massaro, Ana Poblacion, Rino Bellocco, Itai Kloog, Joel Schwartz, Francine Laden, Antonella Zanobetti, Vanoli, J, Coull, B, Ettinger de Cuba, S, Fabian, P, Carnes, F, Massaro, M, Poblacion, A, Bellocco, R, Kloog, I, Schwartz, J, Laden, F, and Zanobetti, A
- Subjects
Fine particulate matter ,Global and Planetary Change ,Children’s weight trajectorie ,Low-income familie ,Epidemiology ,Postnatal exposure ,Health, Toxicology and Mutagenesis ,Varying coefficient model ,Public Health, Environmental and Occupational Health ,Pollution - Abstract
Background: Inconsistent evidence has assessed the impact of air pollution exposure on children’s growth trajectories. We investigated the role of 90-day average postnatal fine particulate matter (PM2.5) exposures by estimating the magnitude of effects at different ages, and the change in child weight trajectory by categories of exposure. Methods: We obtained weight values from electronic health records at each hospital visit (males = 1859, females = 1601) from birth to 6 years old children recruited into the Boston-based Children’s HealthWatch cohort (2009–2014). We applied mixed models, adjusting for individual and maternal confounders using (1) varying-coefficient models allowing for smooth non-linear interaction between age and PM2.5, (2) factor-smooth interaction between age and PM2.5 quartiles. Additionally, we stratified by sex and low birthweight (LBW) status (≤2500 g). Results: Using varying-coefficient models, we found that PM2.5 significantly modified the association between age and weight in males, with a positive association in children younger than 3 years and a negative association afterwards. In boys, for each 10 µg/m3 increase in PM2.5 we found a 2.6% increase (95% confidence interval = 0.8, 4.6) in weight at 1 year of age and a −0.6% (95% confidence interval = −3.9, 2.9) at 5 years. We found similar but smaller changes in females, and no differences comparing growth trajectories across quartiles of PM2.5. Most of the effects were in LBW children and null for normal birthweight children. Conclusions: This study suggests that medium-term postnatal PM2.5 may modify weight trajectories nonlinearly in young children, and that LBW babies are more susceptible than normal-weight infants.
- Published
- 2022
11. DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS
- Author
-
Gino Seravalle, Annalisa Biffi, Jennifer Vanoli, Fosca Quarti-Trevano, Raffaella Dell’oro, Giovanni Corrao, Giuseppe Mncia, Guido Grassi, Seravalle, G, Biffi, A, Vanoli, J, Quarti-Trevano, F, Dell'Oro, R, Corrao, G, Mncia, G, and Grassi, G
- Subjects
Physiology ,Internal Medicine ,Cardiology and Cardiovascular Medicine ,RENAL DENERVATION, BLOOD PRESSURE, SYMPATHETIC NERVE TRAFFIC - Abstract
Objective: Whether and to what extent the reported BP lowering effects of renal denervation (RD) are mediated by a sympathetic deactivation induced by the procedure is still largely undefined. We examined this issue by performing a meta-analysis of the microneurographic studies published so far based on the evaluation of the blood pressure (BP) and muscle sympathetic nerve traffic (MSNA) responses to RD. Design and method: The meta-analysis was based on 12 studies including a total of 394 patients with resistant hypertension underwent RD and followed up to 12 months. Evaluation was extended to the relationships of MSNA with heart rate (HR) and clinic or ambulatory blood pressure (BP) values (expressed such as mean and 95% confidence interval). Results: Baseline MSNA values amounted to 48.25 (43.86-52.64) bursts/minute, clinic HR to 66.35 (65.02-67.67) beats/minute and systo/diastolic clinic BP to 167.3 (157.6-177.01) and 90.54 (84.81-96.27) mmHg. RD caused a significant BP reduction at 3/6/12 months following the procedure amounting to 12.6 mmHg for systolic (range 20.9 to 4.39 mmhg, p = 0.003) and to 6.4 mmHg for diastolic BP (range -11.9 t0 0.9 mmHg, p = 0.02) respectively. No significant change in MSNA (-2.65, range -6.7 to 1.4 bursts/minute, P = NS) and HR (-0.58, range -3.98 to 2.81 b/min, P = NS) were concomitantly observed. No relationship was found between the number of renal ablations and the magnitude of the blood pressure or MSNA changes, this being the case also for HR. Conclusions: This meta-analysis, the first ever done on the MSNA responses to RD, shows that in a consistent number of patients underwent RD, the BP lowering effects of the procedure are not accompanied by any significant change in 2 adrenergic markers, i.e. MSNA and HR, and thus appear not to be mediated by any sympathetic deactivation.
- Published
- 2022
12. Reproducibility of blood pressure phenotypes identified by office and ambulatory blood pressure in treated hypertensive patients. Data from the PHYLLIS study
- Author
-
Giuseppe Mancia, Rita Facchetti, Jennifer Vanoli, Viola Dolfini, Guido Grassi, Mancia, G, Facchetti, R, Vanoli, J, Dolfini, V, and Grassi, G
- Subjects
Physiology ,Reproducibility of Results ,Blood Pressure ,Blood Pressure Monitoring, Ambulatory ,Plaque, Atherosclerotic ,Reproducibility ,Dipping ,Nighttime blood pressure ,Phenotype ,Hypertension ,Internal Medicine ,Humans ,Cardiology and Cardiovascular Medicine ,Hypertensive phenotype ,Antihypertensive Agents - Abstract
Previous studies have shown that white-coat and masked uncontrolled hypertension (WUCH and MUCH, respectively) are clinical conditions with very poor reproducibility over time. This is also the case for the different nighttime blood pressure (BP) patterns (dipping, nondipping, reverse dipping or extreme dipping). Whether and to what extent the phenomenon might depend on the type of antihypertensive treatment is unknown. In the present study, we addressed this issue by analyzing the data collected in the Plaque Hypertension Lipid-Lowering Italian Study (PHYLLIS), in which office and ambulatory BP were measured three times during an almost 3-year treatment period. The results showed that a limited number of WUCH or MUCH patients at an initial office measurement and 24-h systolic (S) BP measurement maintained the same status at a second set of measurements one or more years later. This was also the case for all dipping patterns, and only a minimal number of patients exhibited the same phenotype throughout all on-treatment SBP measurements. The results were similar for treatment with a thiazide diuretic or an ACE inhibitor and are in line with those of the European Lacidipine Study on Atherosclerosis (ELSA) trial, i.e., the only other available trial with multiple on-treatment office and ambulatory BP measurements, in which patients were treated with a calcium channel blocker or a beta-blocker. All the BP patterns identified in hypertensive patients treated by joint office and ambulatory BP measurements display poor reproducibility, and this is unrelated to the type of antihypertensive treatment used.
- Published
- 2022
13. Elevated resting heart rate as independent in-hospital prognostic marker in COVID-19
- Author
-
Jennifer Vanoli, Giacomo Marro, Raffaella Dell'Oro, Rita Facchetti, Fosca Quarti-Trevano, Domenico Spaziani, Guido Grassi, Vanoli, J, Marro, G, Dell'Oro, R, Facchetti, R, Quarti-Trevano, F, Spaziani, D, and Grassi, G
- Subjects
Hospitalization ,sympathetic nervous system ,SARS-CoV-2 ,heart rate ,COVID-19 ,Humans ,coronavirus disease 2019 (COVID-19) ,General Medicine ,Cardiology and Cardiovascular Medicine ,Prognosis ,Hospitals ,prognosi - Abstract
Background: Scarce and non-homogeneous data are available on the prognostic value of clinic heart rate (HR) in coronavirus disease 2019 (COVID-19). Methods: The present study evaluated in 389 patients hospitalized for COVID-19 the in-hospital prognostic value of resting HR, assessed over different time periods, i.e., at hospital admission, during initial 3 days and 7 days of hospitalization. Results: Results show that assessment of this hemodynamic variable during hospitalization provides information on the clinical outcome of the patients, greater HR values being associated with a worse in-hospital prognosis. The prognostic value of elevated HR during COVID-19: 1) was independent on other confounders such as age, gender, comorbidities and fever, 2) appeared to be strengthened by repeated measurements of HR during the initial 3/7 days of hospitalization, and 3) was detectable in patients in which the therapeutic intervention did not include drugs, such as beta-blockers, calcium antagonists, digoxin, ivabradine and antiarrhythmic compounds known to interfere with HR. Conclusions: Heart rate may represent an important marker of a patient’s outcome in COVID-19.
- Published
- 2022
14. WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE
- Author
-
Giuseppe Mancia, Rita Facchetti, Jennifer Vanoli, Raffaella Dell’Oro, Gino Seravalle, Guido Grassi, Seravalle, G, Facchetti, R, Vanoli, J, Dell'Oro, R, Grassi, G, and Mancia, G
- Subjects
glomerular filtration rate ,Physiology ,population ,Blood Pressure ,Blood Pressure Determination ,Blood Pressure Monitoring, Ambulatory ,mortality ,white-coat hypertension, cardiovascular risk, organ damage, long-term risk of mortality ,Hypertension ,Internal Medicine ,Humans ,hypertrophy ,Cardiology and Cardiovascular Medicine ,White Coat Hypertension - Abstract
Background: According to some guidelines, white-coat hypertension (WCH) carries little or no increase of cardiovascular risk in the absence of organ damage (OD), but no data are available on this issue. Methods: Using the population data from PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni), we evaluated cardiovascular and total mortality over a median follow-up of 29 years in WCH (elevated office and normal 24-hour or home blood pressure [BP]) and normotensive controls (normal in- and out-of-office blood pressure) with no echocardiographic left ventricular hypertrophy and no reduction of estimated glomerular filtration rate. Patients with sustained hypertension (SH, in- and out-of-office blood pressure elevation) and normotensive, WCH, and SH with cardiac and renal OD served as controls. Results: In the 1423 subjects analyzed, there were 165 cardiovascular and 526 all-cause deaths. After adjustment for confounders, no-OD WCH exhibited a risk of fatal cardiovascular events lower than that of no-OD SH but greater than that of no-ODN (hazard ratio, 2.0 [95% CI, 1.1–3.6], P =0.02), this being the case also for all-cause mortality. Compared with no-OD normotensive, no-OD WCH also exhibited a greater 10-year adjusted risk to develop new SH or OD. Similar findings were obtained in normotensive, WCH, and SH with OD. Conclusions: The present study provides the first evidence that WCH with no OD is accompanied by a noticeable increase in long-term risk of mortality, new hypertension, and new OD, thereby differing from normotension.
- Published
- 2022
15. ELEVATED RESTING HEART RATE AS INDEPENDENT IN-HOSPITAL PROGNOSTIC MARKER IN COVID-19
- Author
-
Gino Serravalle, Jennifer Vanoli, Raffaella Dell’Oro, Giacomo Marro, Rita Facchetti, Fosca Quarti-Trevano, Domenico Spanziani, Guido Grassi, Serravalle, G, Vanoli, J, Dell'Oro, R, Marro, G, Facchetti, R, Quarti-Trevano, F, Spanziani, D, and Grassi, G
- Subjects
Physiology ,SARS-CoV-2 infection, heart rate, autonomic imbalance ,Internal Medicine ,Cardiology and Cardiovascular Medicine - Abstract
Objective: SARS-CoV-2 infection could be complicated by serious autonomic imbalance caused directly by the virus or through secondary release of inflammatory cytokines. Some studies suggested that elevated resting heart rate (HR) and resting tachycardia, being markers of an increased adrenergic cardiac drive, are associated with poor prognosis in COVID-19 syndrome. Design and method: We performed a retrospective analysis in an inpatient cohort of 389 subjects diagnosed with SARS-CoV-2 infection to investigate the prognostic relevance of HR in predicting the maximum care intensity needed during hospitalization according to the following four severity outcome classes: I) no need for oxygen support/need for low flow oxygen therapy; II) need for high flow oxygen therapy/continuous positive airway pressure; III) transfer to the Intensive Care Unit; IV) death. HR assessments were recorded on admission and during the first 3 and 7 days of hospitalization. Results: For each class increase in maximum care intensity we observed a corresponding significant increase in HR, considering both data collected on admission (average HR value: 90.1 ± 17 beats/minute, p-value trend = 0.0397), and during the first 3 days (p-value trend < 0.0006) or 7 days (p-value trend < 0.0001) of hospitalization. The significant trend was maintained after adjustment for age, sex, comorbidities and fever and in the subpopulation of patients (n = 118) not receiving drugs potentially active on HR both before and during hospitalization. Kaplan-Meier curves for survival based on HR displayed a significant decreased survival in patients with higher HR. Conclusions: The assessment of HR during hospitalization provides information on the clinical outcome of patients affected by SARS-CoV-2 infection independently of other confounders. HR as an in-hospital prognostic marker can be obtained both through a first assessment at the admission or mean values over the course of hospitalization with an increase of its accuracy by a 7-days longitudinal evaluation. Further studies might elucidate the association between SARS-CoV-2 infection with multiple autonomic abnormalities.
- Published
- 2022
16. INCIDENT AORTIC ROOT DILATATION IN THE GENERAL POPULATION: FINDINGS FROM THE PAMELA STUDY
- Author
-
Raffaella Dell'Oro, Marijana Tadic, Giuseppe Mancia, Guido Grassi, Rita Facchetti, Cesare Cuspidi, Fosca Quarti-Trevano, Cuspidi, C, Facchetti, R, Quarti-Trevano, F, Dell'Oro, R, Tadic, M, Mancia, G, Grassi, G, and Vanoli, J
- Subjects
Male ,medicine.medical_specialty ,aortic root dilatation, echocardiography, general population, left ventricular mass ,Ambulatory blood pressure ,Physiology ,Aortic root ,Population ,Aortic Diseases ,Aortic root dilatation ,Blood Pressure ,general population ,Left ventricular mass ,Internal medicine ,Internal Medicine ,Humans ,echocardiography ,Medicine ,education ,Body surface area ,education.field_of_study ,business.industry ,Incidence (epidemiology) ,Blood Pressure Monitoring, Ambulatory ,Middle Aged ,Dilatation ,aortic root dilatation ,risk factor ,left ventricular ma ,cardiovascular system ,Cardiology ,Female ,business ,Cardiology and Cardiovascular Medicine ,Aortic root dilation ,Dilatation, Pathologic - Abstract
AIM We sought to assess the long-term changes in aortic root diameter in a population-based sample, focusing on new-onset aortic root dilatation, as well as on the demographic and clinical variables independently related to this dynamic process. METHODS A total of 1122 participants with measurable echocardiographic parameters at baseline and after a 10-year follow-up were included in the analysis. Sex-specific upper limits of normality for absolute aortic root diameter, aortic root diameter indexed to body surface area (BSA) and to height were derived from 712 healthy normotensive PAMELA participants. RESULTS Over the 10-year follow-up, new aortic root dilatation occurred in 3.4% (aortic root /BSA), 4.4% (aortic root /height) and 7.3% (absolute aortic root), respectively. No substantial relationship was observed between baseline office and ambulatory blood pressure (BP) or their changes over time and incident aortic root /BSA and aortic root /height dilatation. Baseline aortic root diameter and left ventricular mass index (LVMI) emerged as important predictors of aortic root dilation, regardless of the diagnostic criteria used. This was also the case for the 10-year change in LVMI. The strength of association between nonhemodynamic variables and new-onset aortic root dilatation was variable, depending on the definition of the aortic phenotype. CONCLUSION The incidence of aortic root dilatation in a general middle-aged population is a relatively infrequent but not so rare event and scarcely influenced by both office and out-office BP. On the contrary, it is strongly related to LVMI (and its variations over time). From a clinical perspective, this underlines that LVH prevention and regression can reduce the risk of aortic root dilatation in the community.
- Published
- 2022
17. Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report
- Author
-
Guido Grassi, Jennifer Vanoli, Andrea Carrer, Roberto Martorana, Michele Bombelli, Vanoli, J, Carrer, A, Martorana, R, Grassi, G, and Bombelli, M
- Subjects
Hemolytic anemia ,medicine.medical_specialty ,Thrombotic microangiopathy ,Pseudothrombotic thrombocytopenic purpura ,Thrombotic thrombocytopenic purpura ,lcsh:Medicine ,Macrocytosis ,030204 cardiovascular system & hematology ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,hemic and lymphatic diseases ,medicine ,030212 general & internal medicine ,Vitamin B12 ,business.industry ,Microangiopathy ,lcsh:R ,General Medicine ,medicine.disease ,Thrombocytopenic purpura ,Pancytopenia ,Thrombocytopenia ,Vitamin B12 deficiency ,business - Abstract
Background Vitamin B12 deficiency-induced thrombotic microangiopathy, known as pseudothrombotic microangiopathy, is a rare condition which resembles the clinical features of thrombotic thrombocytopenic purpura but requires a markedly different treatment. Most cases of vitamin B12 deficiency have only mild hematological findings, but in approximately 10% of patients life-threatening conditions have been reported. Case presentation We report a case of a 46-year-old Moroccan man presenting with severe hemolytic anemia, thrombocytopenia, and renal failure in absence of macrocytosis, thus mimicking a genuine thrombotic thrombocytopenic purpura. Rapid improvement of renal function observed with only hydration and transfusions of packed red blood cells and the presence of pancytopenia suggested a bone marrow deficiency associated to a hemolytic component of unclear origin. Detection of low levels of vitamin B12 and rapid restitutio ad integrum with its replacement supported the diagnosis of pseudothrombotic thrombocytopenic purpura caused by vitamin B12 deficiency. Conclusions Diagnosis of pseudothrombotic thrombocytopenic purpura caused by vitamin B12 deficiency might be difficult. Awareness of clinicians toward this differential diagnosis might spare patients from unnecessary therapeutic plasma exchange that is burdened by morbidity and mortality.
- Published
- 2018
18. Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease
- Author
-
Guido Grassi, Chiara Lovati, Gino Seravalle, Fosca Quarti-Trevano, Jennifer Vanoli, Seravalle, G, Quarti-Trevano, F, Vanoli, J, Lovati, C, and Grassi, G
- Subjects
medicine.medical_specialty ,Baroreceptor ,Sympathetic Nervous System ,Microneurography ,medicine.medical_treatment ,030232 urology & nephrology ,Pressoreceptors ,Review Article ,030204 cardiovascular system & hematology ,Autonomic Nervous System ,Kidney ,Cardiovascular System ,Kidney transplantation ,Carotid baroreceptor stimulation ,03 medical and health sciences ,0302 clinical medicine ,Diabetes mellitus ,Internal medicine ,medicine ,Sympathetic activity ,Chronic renal failure ,Humans ,Renal Insufficiency, Chronic ,Dialysis ,Parasympathetic activity ,Endocrine and Autonomic Systems ,business.industry ,Dialysi ,medicine.disease ,Autonomic nervous system ,Cardiology ,Renal denervation ,Neurology (clinical) ,Hemodialysis ,business ,Kidney disease - Abstract
Purpose The present paper will review the impact of different therapeutic interventions on the autonomic dysfunction characterizing chronic renal failure. Methods We reviewed the results of the studies carried out in the last few years examining the effects of standard pharmacologic treatment, hemodialysis, kidney transplantation, renal nerve ablation and carotid baroreceptor stimulation on parasympathetic and sympathetic control of the cardiovascular system in patients with renal failure. Results Drugs acting on the renin–angiotensin system as well as central sympatholytic agents have been documented to improve autonomic cardiovascular control. This has also been shown for hemodialysis, although with more heterogeneous results related to the type of dialytic procedure adopted. Kidney transplantation, in contrast, particularly when performed together with the surgical removal of the native diseased kidneys, has been shown to cause profound sympathoinhibitory effects. Finally, a small amount of promising data are available on the potential favorable autonomic effects (particularly the sympathetic ones) of renal nerve ablation and carotid baroreceptor stimulation in chronic kidney disease. Conclusions Further studies are needed to clarify several aspects of the autonomic responses to therapeutic interventions in chronic renal disease. These include (1) the potential to normalize sympathetic activity in uremic patients by the various therapeutic approaches and (2) the definition of the degree of sympathetic deactivation to be achieved during treatment.
- Published
- 2021
19. Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure
- Author
-
Domenico Spaziani, Gino Seravalle, Fosca Quarti-Trevano, Jennifer Vanoli, Guido Grassi, Giuseppe Mancia, Quarti-Trevano, F, Seravalle, G, Spaziani, D, Vanoli, J, Mancia, G, and Grassi, G
- Subjects
Adult ,medicine.medical_specialty ,Baroreceptor ,Central Venous Pressure ,Endocrinology, Diabetes and Metabolism ,RR interval ,Stimulation ,Pressoreceptors ,Blood Pressure ,Stimulus (physiology) ,Baroreflex ,Heart Rate ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Short Research Article ,business.industry ,Central venous pressure ,Chamber pressure ,Short Research Articles ,Pressoreceptor ,Hypertension ,Cardiology ,Reflex ,Cardiology and Cardiovascular Medicine ,business ,Human - Abstract
We examined in 11 young subjects (age 29.7±3.6 years, mean±SEM) whether carotid baroreceptor stimulation via the neck chamber device may affect central venous pressure (CVP), thus potentially involving other reflexogenic areas in the examined responses. Application of progressively greater neck chamber subatmospheric pressures caused a progressive lengthening in RR interval, which reached a peak at the maximal value of negative neck chamber pressure applied. This was accompanied by significant and progressively greater reduction in CVP values when the data were calculated considering the early changes occurring within the first 2 seconds of the stimulus. There was a weak correlation between the early changes in CVP and the RR interval responses when all stimuli were pooled together (r=0.32, P 
- Published
- 2021
20. Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement
- Author
-
Fosca Quarti-Trevano, Gianluca Perseghin, Jennifer Vanoli, Raffaella Dell'Oro, Guido Grassi, Gino Seravalle, Giuseppe Mancia, Grassi, G, Quarti-Trevano, F, Seravalle, G, Dell'Oro, R, Vanoli, J, Perseghin, G, and Mancia, G
- Subjects
Adult ,Male ,sympathetic nervous system ,medicine.medical_specialty ,Sympathetic nervous system ,hypertension ,business.industry ,muscle ,Diastole ,blood pressure ,Blood Pressure Determination ,Sympathetic nerve ,Microneurography ,medicine.anatomical_structure ,Blood pressure ,Internal medicine ,Heart rate ,Internal Medicine ,medicine ,Cardiology ,heart rate ,Humans ,Female ,business - Abstract
Whether blood pressure (BP) values differ when BP is measured with or without the presence of a doctor (attended and unattended BP measurements) is controversial, and no information exists on whether and to what extent neurogenic mechanisms participate at the possible BP differences between these measurements. In this study, we assessed continuous beat-to-beat finger systolic BP and diastolic BP, heart rate, muscle, and skin sympathetic nerve traffic (microneurography) before and during BP measurement by an automatic device in the presence or absence of a doctor. This was done in 18 untreated mild-to-moderate essential hypertensive patients (age, 40.2±2.8 years, mean±SEM). During attended BP measurement, there was an increase in systolic BP, diastolic BP, heart rate, and skin sympathetic nerve traffic and a muscle sympathetic nerve traffic decrease, the peak changes being +5.3%,+8.4%,+9.4%,+30.9%, and −15.2%, respectively ( P
- Published
- 2021
21. Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse
- Author
-
Vincenzo L'Imperio, Marta Riva, Maria Rosa Pozzi, Guido Grassi, Beatrice Vergnano, Gabriele D'Andrea, Jennifer Vanoli, Vanoli, J, Riva, M, Vergnano, B, D'Andrea, G, L'Imperio, V, Pozzi, M, and Grassi, G
- Subjects
Adult ,Male ,medicine.medical_specialty ,Hemoptysis ,Case report, Diffuse alveolar hemorrhage, Extracorporeal membrane oxygenation, Granulomatosis with polyangiitis ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Extracorporeal Membrane Oxygenation ,medicine ,Extracorporeal membrane oxygenation ,Rapidly progressive glomerulonephritis ,case report ,Humans ,030212 general & internal medicine ,Clinical Case Report ,Kidney ,Lung ,diffuse alveolar hemorrhage ,granulomatosis with polyangiitis ,business.industry ,Diffuse alveolar hemorrhage ,General Medicine ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Epididymitis ,business ,Granulomatosis with polyangiitis ,Vasculitis ,Research Article - Abstract
Rationale: Granulomatosis with polyangiitis (GPA) is an antineutrophil cytoplasmatic antibodies (ANCA)-associated vasculitis affecting small- and medium-sized blood vessels, mostly involving lung and kidney. Patient concerns: We report the case of a 33-year-old man that presented with acute respiratory distress syndrome caused by alveolar hemorrhage. Diagnoses: Aggressive GPA presenting with diffuse alveolar hemorrhage and multiorgan involvement. Inteventions: Immunosuppressive therapy, plasma exchange, extracorporeal membrane oxygenation (ECMO). Outcomes: Relapse occurred very early, despite immunosuppressive treatment, with a rare involvement of genital system (epididymitis) and rapidly progressive glomerulonephritis difficult to treat. Lessons: GPA is a challenging, multifaceted disease that can require aggressive supportive therapy and is associated with a high rate of relapse that may present with uncommon site of involvement.
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.